• <listing id="vvvzt"></listing>
    <code id="vvvzt"></code>

    1. <code id="vvvzt"></code><small id="vvvzt"><delect id="vvvzt"></delect></small>
    2. <output id="vvvzt"></output>
      <code id="vvvzt"></code>
            <tt id="vvvzt"><noframes id="vvvzt"></noframes></tt>
              1. <listing id="vvvzt"></listing>

              2. <mark id="vvvzt"><button id="vvvzt"></button></mark>

              3. <tt id="vvvzt"><button id="vvvzt"><td id="vvvzt"></td></button></tt>

                <label id="vvvzt"></label>
                  <label id="vvvzt"></label>
                      <code id="vvvzt"></code>
                    1. <output id="vvvzt"><video id="vvvzt"></video></output>
                    2. <tt id="vvvzt"><button id="vvvzt"><address id="vvvzt"></address></button></tt>

                          1. http://www.tyds.icu
                            Home > Products > Top Products Apixaban Lurasidone > Imatinib Base 20127-57-1 cas 152459-95-5

                            Imatinib Base 20127-57-1 cas 152459-95-5

                            Basic Info

                            Model No.: jianfeng

                            Function: Antineoplastic

                            Grade Standard: Medicine Grade

                            Type: Chemical Reagent

                            State: Solid

                            Volatile: Not Volatile

                            Assay: 99%

                            Product Description
                            Chemical Name: Imatinib
                            Molecular Formula: C29H31N7O
                            Formula Weight: 493.6
                            CAS No.: 152459-95-5


                            Product Name: Imatinib Mesilate

                            CAS NO: 220127-57-1

                            Standard: Enterprise Standard

                            Molecular Formula: C30H35N7O4S

                            Molecular Weight : 589.71

                            Description: White crystal or crystalline powder

                            Package :25KG/drums

                            Chemical names, synonyms:


                            4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate, STI-571, IMATINIB BASE(IMA-3), Imatinib (STI-571) Mesylate


                            Minimum purity: 99%

                            Imatinib Mesilate 220127-57-1

                            Description

                            White to off-white Crystalline Powder

                            Identification By IR

                            IR spectrum of the sample should concordant to the standard spectrum.

                            Solubility

                            Soluble in Water

                            LOD

                            NMT 0.5% w/w

                            Related substance

                            by HPLC

                            Single Max. Imp : NMT 0.1 %

                            Total Max Imp : NMT 1.0 %

                            Assay (By HPLC)

                            NMT 98.0% And NLT 102 %

                            ROI

                            NMT 0.5%

                            Heavy metals

                            NMT 0.5%

                            Thermo gram

                            220-227oC

                            Imatinib Mesylate is a targeted therapy. Imatinib Mesylate is classified as a signal transduction inhibitor - protein-tyrosine kinase inhibitor.

                            A methanesulfonate (mesylate) salt that is the monomesylate salt of imatinib. Used for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours.

                            Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.

                            As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.



                            Looking for ideal Imatinib Mesilate API IMatinib-D4 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Imatinib Base Gleevec are quality guaranteed. We are China Origin Factory of Imatinib Mesilate Intermediate. If you have any question, please feel free to contact us.

                            Product Categories : Top Products Apixaban Lurasidone

                            Email to this supplier
                            • *Subject:
                            • *Messages:
                              Your message must be between 20-8000 characters
                            Communicate with Supplier?Supplier
                            Mr. Vid Mr. Mr. Vid
                            What can I do for you?
                            Contact Supplier
                            浙江快乐彩走势图快乐12基本走势图
                          2. <listing id="vvvzt"></listing>
                            <code id="vvvzt"></code>

                            1. <code id="vvvzt"></code><small id="vvvzt"><delect id="vvvzt"></delect></small>
                            2. <output id="vvvzt"></output>
                              <code id="vvvzt"></code>
                                    <tt id="vvvzt"><noframes id="vvvzt"></noframes></tt>
                                      1. <listing id="vvvzt"></listing>

                                      2. <mark id="vvvzt"><button id="vvvzt"></button></mark>

                                      3. <tt id="vvvzt"><button id="vvvzt"><td id="vvvzt"></td></button></tt>

                                        <label id="vvvzt"></label>
                                          <label id="vvvzt"></label>
                                              <code id="vvvzt"></code>
                                            1. <output id="vvvzt"><video id="vvvzt"></video></output>
                                            2. <tt id="vvvzt"><button id="vvvzt"><address id="vvvzt"></address></button></tt>

                                                  1. <listing id="vvvzt"></listing>
                                                    <code id="vvvzt"></code>

                                                    1. <code id="vvvzt"></code><small id="vvvzt"><delect id="vvvzt"></delect></small>
                                                    2. <output id="vvvzt"></output>
                                                      <code id="vvvzt"></code>
                                                            <tt id="vvvzt"><noframes id="vvvzt"></noframes></tt>
                                                              1. <listing id="vvvzt"></listing>

                                                              2. <mark id="vvvzt"><button id="vvvzt"></button></mark>

                                                              3. <tt id="vvvzt"><button id="vvvzt"><td id="vvvzt"></td></button></tt>

                                                                <label id="vvvzt"></label>
                                                                  <label id="vvvzt"></label>
                                                                      <code id="vvvzt"></code>
                                                                    1. <output id="vvvzt"><video id="vvvzt"></video></output>
                                                                    2. <tt id="vvvzt"><button id="vvvzt"><address id="vvvzt"></address></button></tt>